NX Quanex Building Products CORP
Rolling Drawing & Extruding of Nonferrous Metals · NYSE · SEC CIK 1423221 · Fiscal year ends 10/31
Financial factors as of 2026-07-31 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY1.3%
TTM net income YoY116.0%
TTM EPS YoY115.3%
Revenue 3-yr CAGR17.7%
Net income 3-yr CAGR-17.2%
Margins
Gross margin26.6%
Operating margin6.0%
Net margin2.4%
FCF margin4.9%
EBITDA margin11.3%
Returns
ROE6.2%
ROA2.3%
ROIC (approx.)6.5%
Asset turnover0.95x
Leverage & solvency
Liabilities / assets62.1%
Debt / equity0.89x
Current ratio2.23x
Interest coverage2.23x
Cash quality & payout
Operating cash flow / net income3.21x
Accruals ratio-5.1%
Payout ratio32.1%
Capex / revenue2.9%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-10-31 | FY20242024-10-31 |
|---|---|---|
| Income statement | ||
| Revenue | $1.84B | $1.28B |
| Cost of revenue | $1.34B | $972.24M |
| Gross profit | $499.23M | $305.62M |
| SG&A expense | $277.26M | $190.47M |
| Operating income | -$193.95M | $54.83M |
| Interest expense | $55.81M | $20.59M |
| Pretax income | -$242.59M | $42.08M |
| Income tax | $8.21M | $9.02M |
| Net income | -$250.81M | $33.06M |
| EBITDA | -$90.51M | $115.15M |
| EPS (basic) | -5.43 | 0.91 |
| EPS (diluted) | -5.43 | 0.90 |
| Dividends declared per share | 0.32 | 0.32 |
| Weighted avg. shares (diluted) | 46.17M | 36.65M |
| Balance sheet | ||
| Cash & equivalents | $76.02M | $103.00M |
| Receivables | $205.38M | $197.69M |
| Inventory | $254.12M | $275.55M |
| Current assets | $573.77M | $611.27M |
| PP&E, net | $411.59M | $402.47M |
| Goodwill | $271.35M | $574.71M |
| Intangibles | $549.14M | $597.91M |
| Total assets | $1.97B | $2.32B |
| Current liabilities | $281.55M | $272.87M |
| Short-term debt | $27.56M | $25.75M |
| Long-term debt | $665.27M | $737.20M |
| Total debt | $692.83M | $762.94M |
| Total liabilities | $1.24B | $1.31B |
| Shareholders' equity | $726.18M | $1.01B |
| Net debt | $616.81M | $659.95M |
| Shares outstanding | 45.67M | 47.25M |
| Cash flow statement | ||
| Operating cash flow | $164.90M | $88.81M |
| Capital expenditure | $62.64M | $37.09M |
| Free cash flow | $102.25M | $51.73M |
| Investing cash flow | -$62.01M | -$420.59M |
| Financing cash flow | -$127.48M | $385.16M |
| Depreciation & amortization | $103.44M | $60.33M |
| Stock-based compensation | $3.69M | $2.95M |
| Dividends paid | $14.89M | $11.97M |
| Share buybacks | $32.36M | $0 |
Free plan shows the latest 2 periods; Pro shows all 17 🔒
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.